drugset / Trial / NCT02726477

Efficacy and Safety of Wuling San on Breast Cancer-related Lymphedema

NCT02726477 ↗

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to assess the efficacy and safety of Wuling San, a traditional Chinese medicine, in reducing arm volume excess in women with stage I-II breast cancer related unilateral lymphedema.

Timeline

Start
2016-04
Primary completion
2017-09
Completion
2018-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Wuling San Traditional medicine (herbal / TCM) 1 g/kg —